J B Chemicals & Pharmaceuticals Ltd (JBCHEPHARM) is currently trading at 1,847.15 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

J.B. Chemicals & Pharmaceuticals Limited is a leading pharmaceutical company established in 1976, heavily engaged in the manufacture and marketing of diverse pharmaceutical formulations, herbal remedies, and APIs. The company continues to be one of the fastest growing organizations in the Indian pharmaceutical market, demonstrating superior performance with notable growth in key brands such as Cilacar, Sporlac, and Razel. J.B. Chemicals recently expanded through strategic acquisitions, including the Azmarda brand from Novartis, which fortifies its presence in the cardiology market. The company places a strong focus on expanding its domestic and international presence with a robust order book, driving both revenue and profit growth significantly above the industry average.

Over the past 52 weeks, J B Chemicals & Pharmaceuticals Ltd has traded between a low of ₹1,303.00 and a high of ₹1,939.30. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

J B Chemicals & Pharmaceuticals Ltd has a market capitalization of approximately 29,705.62. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

J B Chemicals & Pharmaceuticals Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 39.33 and operates in the Pharmaceuticals sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

You can buy shares of J B Chemicals & Pharmaceuticals Ltd (JBCHEPHARM) through any SEBI-registered stockbroker in India. A demat and trading account are required to place buy or sell orders on stock exchanges such as NSE or BSE. Shares are credited to the demat account as per the exchange settlement cycle.

Based on its market capitalization of 29,705.62 Cr, J B Chemicals & Pharmaceuticals Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

J B Chemicals & Pharmaceuticals Ltd operates in the Pharmaceuticals sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of J B Chemicals & Pharmaceuticals Ltd is 39.33. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

J B Chemicals & Pharmaceuticals Ltd pays dividends with a current dividend yield of 0.81%. Dividend-paying stocks may provide periodic income in addition to potential long-term capital appreciation.

Key risks associated with J B Chemicals & Pharmaceuticals Ltd include sector-specific challenges in the Pharmaceuticals industry, regulatory changes, competitive pressures, company-level financial performance, overall market volatility, and broader macroeconomic factors that can impact stock prices.